期刊文献+

不同尿液蛋白测定对早期高血压性肾损害的诊断价值及临床意义 被引量:8

Diagnosis value and clinical significance of different urine protein determination to early hypertensive renal damage
原文传递
导出
摘要 目的探讨尿液胱蛋白酶抑制剂C(CystatinC)、α-微量球蛋白(α1-MG)、N-乙酰-β-D-氨基葡萄糖苷酶(NAG)、β2-微球蛋白(β2-MG)和微量白蛋白(mALB)的测定,对高血压早期肾损害诊断的敏感性及其临床意义。方法选择2010年3月-2010年10月在我科住院或门诊体检并明确诊断为原发性高血压患者55例作为病例组,健康体检者38例为对照组。检测两组尿CystatinC、α1-MG、NAG、β2-MG、mALB的含量,并以ROC曲线分析其敏感性。结果病例组尿液中的Cystatin C、α—MG、NAG、β2-MG、mALB含量明显高于正常对照组(P〈0.001),其中尿α1,MG曲线下面积为0.906,β2-MG曲线下面积为0.855,较尿mALB、CystatinC、NAG具有较高的敏感性(P〈0.001)。结论尿α1-MG和β2-MG的检测对诊断高血压早期肾损害的敏感性高于尿mALB、CystatinC和NAG,尿液中不同蛋白的联合检测有助于高血压肾损害的早期监测,对预防高血压性肾病的发生、发展具有重要的临床价值。 Objective To investigate the sensitive index and clinical significance of urine micro proteinase inhibitor C (Cystatin C ), α1-micro globulin (cq-MG), N-acetyl-β-D-amino grape glycosidase (NAG), β2-microballoons protein(β2-MG) and micro albumin (mALB) in early renal injury caused by primary hypertension. Methods 55 patients with primary hypertension from in-patients or out-patientswere enrolled,from March 2010 to October 2010,38 subjects of healthy people for the outpatient were selected as control group. Two groups were examined with urinate Cystatin C,α1-MG, NAG, β2-MG and mALB. Results In hypertension group,urine Cystatin C,α1-MG,NAG,β2-MG and the mALB lever were higher than the normal control group significantly( P 〈 0. 001 ), he area under the urinary α1-MG curve was 0. 906, the area under the urinary β2-MG curve was 0. 855, it was more sensitive compared with urinary mALB, cystatin C and NAG( P 〈 0. 001 ). Conclusions The detection of Urine α1-MG and β2- MG was more sensitive than mALB, Cystatin C and NAG in early renal injury caused by primary hypertension. The five kinds of union examination could be helpful in early detection of hypertensive renel injury, and there were important clinical value in the prevention of hypertensive renel injury.
出处 《临床内科杂志》 CAS 2011年第8期527-529,共3页 Journal of Clinical Internal Medicine
关键词 尿液胱蛋白酶抑制剂C α1-微量球蛋白 N-乙酰-Β-D-氨基葡萄糖苷酶 Β2-微球蛋白 微量白蛋白 高血压早期肾损害 Urinates Cystatin C α1-MG NAG β2-MG mALB Hypertension early time kidney harm
  • 相关文献

参考文献12

二级参考文献42

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2李锦祥,柏萍,俞建华.冠心病患者同型半胱氨酸水平变化与血管内皮功能的关系[J].实用诊断与治疗杂志,2005,19(5):327-328. 被引量:13
  • 3[6]Berggard I, Bearn AG. Isolation and properties of a low molecular weight β2-globulin occurring in human biological fluid [J]. J Biol Chem, 1968, 243 (15): 4095.
  • 4[9]Franklin SS, Khan SA, Wong ND, et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study [J]. Circulation, 1999, 100 (4): 354-360.
  • 5[10]Verdecchia P, Schilaci G, Borgioni C, et al. Ambulatory pulse pressure: a potent predctor of total cardiovascular risk in hypertension [J]. Hypertension, 1998, 32 (6): 983-988.
  • 6[11]Madthavan S, Ooi WL, Cohen H, et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction [J]. Hypertension, 1994, 23: 395-401.
  • 7林青,福建医科大学学报,1998年,32卷,50页
  • 8魏有仁,生物化学与生物物理进展,1995年,22卷,169页
  • 9Wu J T,J Clin Lab Anal,1993年,7卷,252页
  • 10于宏,实用高血压学,1993年,878页

共引文献364

同被引文献76

  • 1秦瑞香.尿α_1-m、β_2-m、Alb的检测在SLE患者早期肾损害中的意义[J].放射免疫学杂志,2005,18(3):214-215. 被引量:20
  • 2Jarvela K, Maaranen P, Harmoinen A. Cystatin C in diabetics as a marker of mild renal insufficiency after CABG [J]. Annals of Tho- racic and Cardiovascular Surgery, 2011, 3 (5): 89-90.
  • 3Riskin-Mashiah S, Damti A, Younes G. First trimester fasting hyper- glycemia as a predictor for the development of gestational diabetes mellitus [J]. European Journal of Obstetrics & Gynecology and Re- productive Biology, 2010, 8(2): 218-219.
  • 4Grubb A. Non-invasive estimation of glomerualr filtration rate (GFR). The Lurid model, simultaneous use of cystatin C-and creati- nine-besed GFR-predietion equations, clinical data and an internal quality check [J]. Scand J of Clin Lab Inves, 2010, 8(4): 398-399.
  • 5L6pez G6mez JM, Sacrisffm Enciso B, Mic6 M.Alejo S Serum cys- Latin C and microalbuminuria in the detection of vascular and renal damage in early stages [J]. Nefrologia, 2011, 5 (3) : 698-699.
  • 6Scholze J, Bramlage P, Trenkwalder E Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily prac- tice. A comparison of office, self-measured and ambulatory blood pressure [J]. Expert Opinion on Pbarmacotherapy, 2011, 18(2): 471-472.
  • 7中国高血压防治指南修订委员会.2011年高血压诊治指南[J].中华心血管杂志,2011,9(7):579-616.
  • 8Ruilope LKThe kidney as a sensor of cardiovascular risk in essential hypertension[J].J Am Soc Nephrol, 2002,13(Suppl 3):165-168.
  • 9Stam F, Van Guldener C,Schalkwijk CG,et al. impaired renal function is associated with markers of endo- thelial dysfunction and increased inflammatory ac- tivity[J].Nephrol Dial Transplant,2003,18 (5):892- 898.
  • 10中国高血压防治指南修订委员会.中国高血压防治指南2005年修订版全文[J].高血压杂志,2005,13(增刊):1-40.

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部